Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Annals of Internal Medicine|February 1, 1982
Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's diseaseA Santoro, V Bonfante, G Bonadonna
Tumori|April 30, 1982
Toxic and therapeutic activity of 4'-epi-doxorubicinV Bonfante, F Villani, G Bonadonna
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Preliminary clinical experience with 4-epidoxorubicin in advanced human neoplasiaV Bonfante, G Bonadonna, F Villani, et al.
The New England Journal of Medicine|April 1, 1982
Alternating drug combinations in the treatment of advanced Hodgkin's diseaseA Santoro, G Bonadonna, V Bonfante, et al.
Tumori|April 30, 1988
Phase II study with ifosfamide in advanced malignant melanomaE Negretti, L Ferrari, V Bonfante, et al.
Investigational New Drugs|January 1, 1983
Phase I study of 4-demethoxydaunorubicinV Bonfante, L Ferrari, F Villani, et al.
Cancer Treatment Reports|December 1, 1986
Cytarabine and cisplatin in advanced malignant melanomaE Bajetta, C Verusio, V Bonfante, et al.
Behavioural Pharmacology|April 26, 2000
The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic functionR Dall'Olio, R Gaggi, V Bonfante, et al.
Cancer Treatment Reports|April 1, 1982
Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent resultsG Bonadonna, A Santoro, V Bonfante, et al.
Seminars in Oncology|March 1, 1986
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's diseaseA Santoro, S Viviani, P Valagussa, et al.
Pageof 5